Clinical Trial Update: Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy data for AAE581 in postmenopausal women with osteoporosis. The study is sponsored by Novartis and has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AAE581

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED